Aline Barth

Aline Barth is an accomplished professional in clinical pharmacology and pharmacometrics, currently serving as Vice President and Head of Clinical Pharmacology and Pharmacometrics at Structure Therapeutics since July 2023. Previously, Aline held the position of Senior Director and Head of Clinical Pharmacology at Global Blood Therapeutics before its acquisition by Pfizer from June 2021 to July 2023. Aline's extensive experience also includes roles as a Lecturer at the Drug Development in Brazil Network from August 2017 to August 2021, Director and Manager of Clinical Pharmacology Modeling and Simulation at GSK from June 2017 to June 2021, and Senior Scientist at Merck from August 2014 to May 2017. Aline earned a PhD in Pharmaceutical Sciences from the University of Florida, complemented by a Master's in Pharmaceutical Sciences and a Bachelor's in Pharmacy from the Federal University of Rio Grande do Sul, where an Industrial Pharmacist degree was also obtained.